Home / Posts tagged "Cannabis"

Cannabis

Spot light on NZ MC companies – SOMA

Q1. Who are you, where are you based and what do you do? SOMA Group is New Zealand’s leading science-based medical cannabis company. The only end-to-end business in the market, we’re also the only science wholesaler with a national research programme collaborating with the University of Otago, and the only business focussed on matching whole plant and human genetics (endocannabinoids).Based...
Read More

Spot light on NZ MC companies – Rua Bioscience

Q1. Who are you, where are you based and what do you do? Rua Bioscience is a medicinal cannabis company from Tairāwhiti. Founded in 2016 initially as a subsidiary of charitable company Hikurangi Enterprises, Rua Bioscience aspires to be a global innovator in cannabis breeding and genetics, cultivation and product innovation. The company has two licensed cultivation sites near Ruatoria and a med...
Read More

Spot light on NZ MC companies – Puro

Q1. Who are you, where are you based and what do you do? Puro, Marlborough. Cultivation of cannabis and hemp for medical end use. Q2. Will you offer compassionate discounts, (community service card holders, pensioners etc)? Puro sell to pharmaceutical companies and extraction partners. We don’t sell direct to consumer. Q3. Do you have plans for trials regarding chronic pain? No. Q4. What c...
Read More

Spot light on NZ MC companies – NUBU Pharmaceuticals

NUBU Pharmaceuticals' logo
Q1. Who are you, where are you based and what do you do? My name is Mark Dye, and I am the CEO of Auckland based NUBU Pharmaceuticals. Q2. Will you offer compassionate discounts, (community service card holders, pensioners etc)? I am unable to answer this question as suppliers of unapproved medicines are unable to communicate in a manner that Medsafe would consider advertising. Sorry. Q3. Do...
Read More

Spot light on NZ MC companies – Medleaf Therapeutics

Q1. Who are you, where are you based and what do you do? Courtney Letica, Auckland, CEO of Medleaf Therapeutics Q2. Will you offer compassionate discounts, (community service card holders, pensioners etc)? We offer the best price to market and will continue to do so. This is our business model. Q3. Do you have plans for trials regarding chronic pain? No. Q4. What certification programs, i....
Read More

Spot light on NZ MC companies – Helius Therapeutics

Q1. Who are you, where are you based and what do you do? Helius is one of New Zealand’s largest licensed medical cannabis companies and we exist to improve quality of life. Our first priority is to provide high-quality, affordable medicinal cannabis to kiwi patients across the country.We have a bold vision, to become a world leader in the research and development of safe and efficacious med...
Read More

MCANZ Press Release: New Medical Cannabis Regulations “Bittersweet”

PRESS RELEASE:  Unveiling of Medical Cannabis regulations "Bittersweet" Today, the Medical Cannabis Regulations have been released, the reaction from patients has been mixed, with some excellent gains made around prescribers and access pathways, leaving the patients uphill battle for access squarely as a socio-economic issue.Prescribing Unleashed "The unleashing of GP Prescribing for is a gr...
Read More

DIPG, Elyse Defying the odds, nearly 4 years and going strong.

Article by Casey Johnson, Mother to Elyse, a follow up to this earlier post from 2018Hi my name is Casey. I’m a wife and mother to two children, Blake 9yrs and Elyse 6yrs.We had a perfect life that was soon to be shattered. I’ll tell you a bit about our story.The past 3 years 8 months have proven to be some of the hardest yet greatest and most rewarding moments of my life.Elyse, my...
Read More

MCANZ Press release: Leaked email reveals World Health Organisation Recommends Rescheduling Cannabis

Late last year, the World Health Organisation (WHO) held the 41st meeting of the Expert Committee of Drug Dependence (ECDD). This was a historic meeting as it was the first review of Cannabis scheduling in international treaties since before the existence of the UN or WHO.After a delay in reporting the results due to suspected political pressure, an internal letter to the UN Secretary-Gene...
Read More

Medicinal Cannabis—Potential Drug Interactions

Original article found hereMuhammad A. Alsherbiny 1,2,*  and Chun Guang Li 1,* 1 NICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia2 Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, EgyptAbstract The endocannabinoids system (ECS) has garnered considerable interest as a potential therapeutic target in var...
Read More
Top